RT Journal Article
SR Electronic
T1 Seroprevalence of Chagas in urban and rural indigenous populations of the south of Gran Chaco
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.11.21249585
DO 10.1101/2021.01.11.21249585
A1 Colussi, Carlina
A1 Stafuza, Mariana
A1 Nepote, Marcelo
A1 Mendicino, Diego
YR 2021
UL http://medrxiv.org/content/early/2021/01/13/2021.01.11.21249585.abstract
AB Background & objectives In Latin America, Chagas disease is endemic, with high prevalence in rural indigenous communities and increasing prevalence in urban areas due to migration from rural areas with active vector transmission. The objective of the work was to assess differences in the prevalence of Chagas disease in urban and rural moqoit communities of the south of Gran Chaco, Santa Fe province, Argentina.Methods A seroprevalence study was conducted in six moqoit populations. Belonging to an urban community was considered as an exposure variable, whereas seropositivity for Chagas disease was considered as an outcome variableResults The results showed that 9.26% of the 702 volunteers evaluated and 3.50% of women of childbearing potential were seropositive. The prevalence of Chagas disease in urban communities was 6.41 times higher than in rural communities.Interpretation & conclusions The seroprevalence found in the moqoit community is higher than that estimated for the general population of the same region, with greater impact in the urban area than in the rural area. The decline of vector transmission in the rural area could be related to the conservation of ancestral practices and the expansion of the agricultural model.Competing Interest StatementThe authors have declared no competing interest.Funding StatementCAI+D-UNLAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was evaluated and approved by the Ethics and Security Advisory Committee in Research of the School of Biochemistry and Biological Sciences of the Universidad Nacional del Litoral, Santa Fe, Argentina (Act No. 03/12)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are not any supplement data available